Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
Despite the widespread awareness that hypertension and dyslipidemia are risk factors of prime importance for cardiovascular disease, the prevalence of these risk factors is still high, and the success of their control can hardly be considered satisfactory. The latest European guidelines for the mana...
Saved in:
| Main Authors: | Z. D. Kobalava, E. V. Kokhan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2020-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2315 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipitension – myth or reality? Opinion of a practicing cardiologist (letter to the editor)
by: V. V. Kashtalap
Published: (2024-10-01) -
Effective polypill therapy in patients with hypertension and dyslipidemia
by: V. E. Oleynikov, et al.
Published: (2025-07-01) -
Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation)
by: V. V. Kashtalap
Published: (2022-12-01) -
Lipitension today — disaster tomorrow: focus on elderly comorbid patients
by: A. S. Skotnikov, et al.
Published: (2025-05-01) -
The way to effective prevention of cardiovascular complications: review
by: L. D. Khidirova, et al.
Published: (2024-11-01)